Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17250
Corporate User License Price USD 750
Corporate User License Price INR 51750
Site License Price USD 500
Site License Price INR 34500
Request a Quote

Report Title

Oklahoma Medical Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Oklahoma Medical Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Oklahoma Medical Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Oklahoma Medical Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Oklahoma Medical Research Foundation (OMRF) is a non-profit biomedical research institute. The institute conducts disease research for human diseases such as lupus, alzheimer's and diseases of aging, diabetics, cancer, children's disease, autoimmune disease and heart diseases. Its portfolio of research programs includes Cell Cycle and Cancer Biology Research Program, Aging and Metabolism Research Program, and Cardiovascular Biology Research Program, Functional and Chemical Genomics Research Program, among others. OMRF's Technology Ventures seeks to work in partnership with other organizations to develop and commercialize the technologies. The institute also provides graduate education programs that include the scholarships and mentoring for doctoral students. OMRF is headquartered in Oklahoma City, Oklahoma, the US.

Oklahoma Medical Research Foundation-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Oklahoma Medical Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Otologic Pharma Raises USD 4.1 Million In Series A Financing 12

Oklahoma Medical Research Raises USD 1 Million In Seed Financing 13

Partnerships 14

Oklahoma Medical Research Foundation Enters into Agreement with GlaxoSmithKline 14

Q BioMed Enters into Agreement with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology 15

Eisai Enters into Research Agreement with Oklahoma Medical Research Foundation 16

Progentec Diagnostics Enters into Agreement with Oklahoma Medical Research Foundation 17

Licensing Agreements 18

Shanghai RAAS Enters into Licensing Agreement with Oklahoma Medical Research 18

Q BioMed Enters into Licensing Agreement with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology 19

Xonovo Enters into Licensing Agreement with Oklahoma Medical Research Foundation 20

Asset Transactions 21

GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 21

Oklahoma Medical Research Foundation-Key Competitors 22

Oklahoma Medical Research Foundation-Key Employees 23

Oklahoma Medical Research Foundation-Locations And Subsidiaries 26

Head Office 26

Recent Developments 27

Legal and Regulatory 27

Sep 13, 2017: OMRF Genomics Center earns CAP accreditation 27

Government and Public Interest 28

Aug 27, 2018: OMRF receives USD 1.4 million to study DNA errors in birth defects, diseases 28

Aug 23, 2018: OMRF receives USD 2.8 million grant to study rare disorder 29

Jul 30, 2018: Presbyterian Health Foundation awards USD 3.5 million in grants to OMRF, OUHSC 30

Jul 02, 2018: OMRF receives USD 2.1 million to study cell division 31

Apr 23, 2018: Experts propose improving clinical trials for lupus 32

Apr 18, 2018: Discovery Could Explain Cell Division Errors in Cancer 33

Apr 04, 2018: OMRF discovers new approach to treating obesity 34

Mar 19, 2018: OMRF discovery could lead to new therapies for MS 35

Feb 26, 2018: OMRF receives USD 2.25 million grant to study vision loss 36

Feb 08, 2018: OMRF postdoc receives national aging reward 37

Jan 15, 2018: The Kirschner Trusts award USD 6,000 grant to OMRF researcher 38

Dec 27, 2017: Rapp Foundation gives USD 400,000 to OMRF for new researchers 39

Dec 20, 2017: OMRF researchers identify genes that may cause cancer to recur after treatment 40

Nov 07, 2017: OMRF researcher receives Alzheimer's grant 41

Oct 19, 2017: OMRF research shows how exercise can benefit cartilage 42

Oct 06, 2017: Putnam City donates USD 90,000 to cancer research at OMRF 43

Aug 08, 2017: OMRF receives four grants totaling more than USD 5 million 44

Aug 03, 2017: Findings yield new clues to puzzling autoimmune disease 45

Jul 26, 2017: Oklahoma researchers zero in on cause of blood disorder 46

Jul 19, 2017: International study reveals 24 new genes associated with lupus 47

Jul 17, 2017: Presbyterian Health Foundation awards more than USD 3.7 million in grants to OUHSC, OMRF 49

Jun 21, 2017: OMRF receives new grants to study blood clotting, ovarian cancer 50

May 18, 2017: Researchers identify gene associated with lupus 51

May 08, 2017: OMRF makes new findings related to colon cancer gene 52

Mar 16, 2017: OMRF receives grant to study triggers of cancer, birth defects 53

Feb 16, 2017: Researchers make new insights into birth defects, infertility 54

Jan 26, 2017: OMRF researcher receives rheumatology award 55

Jan 23, 2017: OMRF part of research team that receives USD 9 million aging grant 56

Jan 12, 2017: Hearst Foundations make grant to OMRF 57

Jan 03, 2017: OMRF receives federal grant to investigate cell death 58

Appendix 59

Methodology 59

About GlobalData 59

Contact Us 59

Disclaimer 59

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Oklahoma Medical Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Key Facts 2

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oklahoma Medical Research Foundation, Deals By Therapy Area, 2012 to YTD 2018 9

Oklahoma Medical Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10

Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Otologic Pharma Raises USD 4.1 Million In Series A Financing 12

Oklahoma Medical Research Raises USD 1 Million In Seed Financing 13

Oklahoma Medical Research Foundation Enters into Agreement with GlaxoSmithKline 14

Q BioMed Enters into Agreement with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology 15

Eisai Enters into Research Agreement with Oklahoma Medical Research Foundation 16

Progentec Diagnostics Enters into Agreement with Oklahoma Medical Research Foundation 17

Shanghai RAAS Enters into Licensing Agreement with Oklahoma Medical Research 18

Q BioMed Enters into Licensing Agreement with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology 19

Xonovo Enters into Licensing Agreement with Oklahoma Medical Research Foundation 20

GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 21

Oklahoma Medical Research Foundation, Key Competitors 22

Oklahoma Medical Research Foundation, Key Employees 23

Oklahoma Medical Research Foundation, Key Employees (cont..) 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Oklahoma Medical Research Foundation, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person